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Bacterial sensing by intracellular Nod proteins and
other Nod-like receptors (NLRs) activates signaling
pathways that mediate inflammation and pathogen
clearance. Nod1 and Nod2 associate with the kinase
Rip2 to stimulate NF-kB signaling. Other cytosolic
NLRs assemble caspase-1-activating multiprotein
complexes termed inflammasomes. Caspase-12
modulates the caspase-1 inflammasome, but unlike
other NLRs, Nod1 and Nod2 have not been linked to
caspases, and mechanisms regulating the Nod-Rip2
complex are less clear. We report that caspase-12
dampens mucosal immunity to bacterial infection
independent of its effects on caspase-1. Caspase-
12 deficiency enhances production of antimicrobial
peptides, cytokines, and chemokines to entric patho-
gens, an effect dependent on bacterial type III secre-
tion and the Nod pathway. Mechanistically, caspase-
12 binds to Rip2, displacing Traf6 from the signaling
complex, inhibiting its ubiquitin ligase activity, and
blunting NF-kB activation. Nod activation and result-
ing antimicrobial peptide production constitute an
early innate defense mechanism, and caspase-12
inhibits this mucosal antimicrobial response.
INTRODUCTION
Innate immunity is the first line of defense against pathogens.
Within minutes to hours, it recognizes the pathogen and induces
a broad antimicrobial response to eradicate it. Among the effec-
tors of innate immunity are pathogen recognition receptors
(PRRs) that detect specific signature molecules, not normally
found on host cells, but presented by the pathogen itself (patho-
gen-associated molecular patterns or PAMPs) or by the infected
host cell (danger-associated molecular patterns [DAMPs] or
alarmins). PRRs include membrane-bound toll-like receptors
(TLRs) and cytosolic NOD-like receptors (NLRs). In response to
infection, they are engaged and activate multiple downstream
signaling pathways, which culminate in a local inflammatory
response. While TLRs turn on the NF-kB and MAPK pathways146 Cell Host & Microbe 3, 146–157, March 2008 ª2008 Elsevier Inc(Kawai and Akira, 2007), NLRs generally assemble inflamma-
somes and activate caspase-1, which is essential for the pro-
cessing and maturation of key proinflammatory cytokines (Nadiri
et al., 2006).
In the gut, intestinal epithelial cells have adapted mechanisms
to coexist with enteric commensal bacteria without mounting an
inflammatory response to their presence. TLR expression and
distribution on the enterocyte surface contribute to this homeo-
stasis. Notably, normal enterocytes express low levels of TLR2,
TLR4, and the coreceptor MD-2 and lack membrane-bound
CD14, which is a coreceptor for lipopolysaccharide (Abreu
et al., 2001; Otte et al., 2004). Enteric pathogens and commensal
bacteria express several genes necessary for a lifestyle involving
intestinal colonization and environmental transmission. How-
ever, they additionally harbor genomic islands of pathogenicity
necessary for the expression of factors required for virulence. At-
taching and effacing pathogens, which include enteropatho-
genic Escherichia coli (EPEC), enterohemorrhagic E. coli
(EHEC), and Citrobacter rodentium, carry a pathogenicity island
termed locus of enterocyte effacement (LEE), responsible for the
bacteria’s ability to induce lesions on epithelial cells (Jores et al.,
2004). EPEC and EHEC infect domestic animals and humans
and are a major cause of infantile infectious diarrhea in develop-
ing countries and food- and water-associated outbreaks in
developed countries, respectively. C. rodentium is a natural
mouse pathogen (Mundy et al., 2005) that produces attaching
and effacing lesions in the colon indistinguishable from those
caused by clinical EPEC and EHEC strains. Infection of mice
with C. rodentium causes an infectious colitis characterized by
crypt hyperplasia, loss of goblet cells, mucosal infiltration with
macrophages and neutrophils, and a local Th1 inflammatory re-
sponse similar to that seen in mouse models of inflammatory
bowel disease. Little is known, however, about the innate im-
mune mechanisms involved in the detection and consequent
clearance of this family of pathogens. TLR4 signaling is required
for the colitis phenotype induced by C. rodentium; however, it is
dispensable for bacterial clearance (Khan et al., 2006), suggest-
ing that other innate immune mechanisms are required for the
eradication of this pathogen.
Nod1 and Nod2 proteins play an important role in the mucosal
innate immune response to various enteric pathogens, including
H. pylori (Viala et al., 2004) and L. monocytogenes (Kobayashi
et al., 2005), respectively. Their localization in the cytosol favors.
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ing or injecting bacterial products into the cytosol. In response to
different motifs in the bacterial cell wall component peptidogly-
can, Nod proteins associate with the kinase Rip2 to stimulate
the NF-kB pathway (Park et al., 2007). This is accomplished
through the recruitment of the E3 ubiquitin ligase Traf6 to Rip2,
followed by Traf6 autoubiquitination, polyubiquitination of Rip2,
and ubiquitin-dependent signaling and activation of the TAB2-
TAK1 kinase complex. These events are required for the stimu-
lation of the IKK kinase complex downstream of Nod signaling,
leading to NF-kB activation (Abbott et al., 2007). The Nod path-
way has been linked to the production of essential gastrointesti-
nal cationic antimicrobial peptides, specifically defensins. De-
fective synthesis of these peptides renders Nod2/ mice
susceptible to oral infection with Listeria monocytogenes (Ko-
bayashi et al., 2005). In humans, mutations in the Nod2 gene
(Ogura et al., 2001; Hugot et al., 2001), as well as impaired defen-
sin production (Wehkamp et al., 2004), have been linked to
Crohn’s disease (CD), an inflammatory bowel disorder that af-
fects the entire human intestine. Nod1 is similarly required for
the production of certain defensins by epithelial cells during Hel-
icobacter pylori (Boughan et al., 2006) and Campylobacter jejuni
(Zilbauer et al., 2007) infection. Nod1 and Nod2 have a caspase
recruitment domain (CARD) in their N termini, a central nucleo-
tide-binding domain (NOD), and a C-terminal leucine-rich repeat
domain (LRR). However, unlike other NLRs, Nod1 and Nod2
have not been directly linked to caspase-1 activation in vivo.
While modulators of the caspase-1 inflammasomes have been
identified (Scott and Saleh, 2007), it is less clear how the Nod-
Rip2 complex is regulated.
Caspase-1 signaling is essential for systemic bacterial clear-
ance (Joshi et al., 2002), but its role in mucosal immunity is
less defined. We have previously shown that caspase-12 is
a negative regulator of caspase-1, and that caspase-12-defi-
cient macrophages hyperproduced IL-1b and IL-18, two proin-
flammatory cytokines processed and matured by caspase-1
(Saleh et al., 2006). This enhancement of cytokine production
by caspase-12/ mice translated into their ability to clear sys-
temic Listeria monocytogenes infection more efficiently than
wild-type mice and to resist polymicrobial sepsis-related mortal-
ity (Saleh et al., 2006). Notably, caspase-12 exerted its inhibitory
effects on the caspase-1 pathway independently of its catalytic
activity (Saleh et al., 2006). Rodent caspase-12 has acquired
a mutation in its catalytic pocket that renders it an extremely in-
efficient enzyme. Thus far, the only known substrate for cas-
pase-12 is caspase-12 itself, and the mechanism by which this
autoprocessing occurs is distinct from that used by other
caspases, as it is not blocked by the pan-caspase inhibitor
zVAD-FMK.
Caspase-12 is highly expressed in intestinal epithelial cells.
Using bone marrow chimera experiments, we have previously
shown that the effects of caspase-12 in sepsis and bacterial in-
fection were not restricted to its actions in the hematopoietic
compartment (Saleh et al., 2006). Here we show that, in entero-
cytes, caspase-12 is recruited to the Nod complex and modu-
lates Nod signaling at the mucosal interface. Intestinal epithelial
cells of caspase-12-deficient mice infected with C. rodentium
hyperproduced b-defensins and a subset of chemokines in
a Nod-dependent manner. This resulted in an early inhibition ofCbacterial growth and a less severe pathology in caspase-12-de-
ficient mice compared to wild-type mice. We conclude that Nod
activation and the downstream antimicrobial peptide production
constitute an early innate defense mechanism to attaching and
effacing bacteria and that caspase-12 is an inhibitor of this
mucosal antimicrobial response.
RESULTS
Caspase-12/ Mice Restricted C. rodentium Bacterial
Growth Very Early during Infection
To investigate the role of caspase-12 in mucosal innate immu-
nity, we infected by oral gavage caspase-12 null mutant
C57Bl/6 mice and wild-type mice with the extracellular noninva-
sive Gram-negative bacteria C. rodentium. C57Bl/6 mice are rel-
atively resistant to C. rodentium and clear the infection within 3
weeks (Figure 1A). At the peak of infection, C. rodentium induces
an infectious colitis phenotype in wild-type mice that is mediated
by infiltrating macrophages and neutrophils in the infected colon
(Figure 1A). We originally hypothesized that, since caspase-12
inhibited the caspase-1 inflammatory pathway, caspase-12-de-
ficient mice would exhibit a more severe colonic inflammation
compared to wild-type mice. Surprisingly, we found that, while
infection of wild-type mice followed the reported kinetics (Fig-
ures 1A and 1B), with bacterial growth occurring within the first
10 days after bacterial gavage and clearance taking place be-
tween days 11 and 22, caspase-12-deficient mice had signifi-
cantly lower bacterial content compared to wild-type mice as
early as day 2 postinfection (Figure 1B). This difference in C.
rodentium colony-forming units (CFUs) was evident when we
quantified the bacteria in both fecal pellets (Figure 1B), as well
as in ceca and colons of infected mice (Figure 1C).
Caspase-12/ Mice Exhibited a Less Severe Colonic
Inflammation and Pathology in Response
to C. rodentium Infection
Colonic inflammation and pathology induced by C. rodentium
peak between days 10 and 14 postinfection in C57Bl/6 mice.
The lower bacterial content we observed in caspase-12/
mice suggested that these mice would suffer a less severe pa-
thology compared to wild-type mice. To examine this hypothe-
sis, we assessed colonic sections obtained from mice on days
7 or 14 postinfection for different histological and pathological
criteria, including the presence of attaching and effacing bacte-
ria, lesions in the colon, and mucosal inflammatory infiltrate.
While we were able to clearly identify attaching and effacing bac-
teria on the surface of epithelial cells in colonic sections from
wild-type mice, we detected less bacteria in colonic sections
from caspase-12/ mice (Figure 2A). Consistently, sections
from wild-type animals exhibited higher number of inflammatory
infiltrate and lesions in the colon compared to those from cas-
pase-12/ mice (Figure 2B). To characterize the nature of infil-
trating cells, we stained by immunofluorescence colonic sec-
tions derived from both mouse genotypes with F4/80, Gr-1,
and CD4 antibodies, which selectively label macrophages, neu-
trophils, and CD4 T cells, respectively. Colonic sections from
wild-type mice, obtained on day 14 postinfection, had a severe
infiltration of macrophages, neutrophils, and T cells (Figure 2C,
left panels). In contrast, sections from caspase-12-deficientell Host & Microbe 3, 146–157, March 2008 ª2008 Elsevier Inc. 147
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with F4/80, Gr-1, or CD4 antibodies (Figure 2C, right panels).
Consistent with the lower bacterial content and inflammatory
infiltrate, we observed by histology and immunofluorescence
experiments in caspase-12-deficient mice compared to wild-
type mice (Figures 2A–2C), there were significantly lower levels
of the cytokine IL-1b and chemokine MIP-2 at the peak of infec-
tion in colon extracts from caspase-12/ mice compared to
those from wild-type mice (Figure 2D).
Caspase-12-Deficient Intestinal Epithelial Cells
Hyperproduce Antimicrobial Peptides Independently
of Caspase-1 Activity
It was conceivable that the early difference in C. rodentium con-
tent between the two mouse genotypes was due to an unusually
early and excessive infiltration of phagocytes occurring in the
ceca and colons of caspase-12/ mice. We examined this by
staining cecal and colonic sections obtained on day 3 postinfec-
tion with F4/80 and Gr-1 antibodies. We could not detect inflam-
matory infiltrate at this early stage of infection in both mouse
genotypes (Figure 3A), consistent with what has been reported
for C57Bl/6 mice in this model. This suggested that C. rodentium
Figure 1. Caspase-12/ Mice Restrict C.
rodentium Growth Early on during Infection
(A) A schematic representation of C. rodentium in-
fection kinetics in C57BL/6 mice. Bacterial growth
occurs within the first 11 days postinfection, while
bacterial clearance is from day 11 to 22. At the
peak of infection, C. rodentium induces an infec-
tious colitis phenotype mediated by infiltrating
neutrophils and macrophages.
(B) Lower bacterial counts in the fecal pellets of
caspase-12/ mice compared to wild-type mice
as early as day 2 postinfection. Data show the
mean ± SEM. n = 10 mice per genotype.
(C) The ceca and colons of caspase-12/ mice
had lower C. rodentium content than those of
wild-type mice. A horizontal line represents the
average. n = 7 mice per time point per genotype,
except for day 14, where n = 3 mice per genotype.
ns, not significant.
was not excessively phagocytosed in
caspase-12-deficient mice, and that the
mechanism leading to the restriction of
its growth at early time points is indepen-
dent of macrophages and neutrophils. C.
rodentium is known to colonize the
cecum first before translocating to the
colon. To understand the effector mecha-
nisms resulting in C. rodentium killing, we
first addressed whether the caspase-1
inflammatory pathway was hyperacti-
vated in caspase-12/ mice in the ce-
cum at early time points of infection (day
3) and then in the colon at day 7 postin-
fection. We quantified the levels of pro-
IL-1b produced in the ceca throughout
the infection. qPCR results showed that,
at early time points (8 hr and day 3 postinfection), there was an
equivalent level of pro-IL-1b message produced in wild-type
and caspase-12-deficient tissues, and that at later time points
(days 7 and 14), IL-1b levels became higher in wild-type cecal ex-
tracts compared to knockout extracts (Figure 3B), consistent
with the higher bacterial content in ceca of wild-type mice com-
pared to those of caspase-12-deficient mice (Figure 1C, left
panel). We measured the amount of mature IL-1b levels as
a read-out of caspase-1 activity using ELISA assays at early
time points when pro-IL-1b levels were similar in the two mouse
genotypes. No significant difference was found in IL-1b levels in
the ceca of wild-type and caspase-12/ mice at day 3 postin-
fection (Figure 3C). In the colon, we chose to quantify IL-1b levels
at day 7 postinfection. Again, no significant difference was ob-
served in IL-1b levels in the colons of wild-type and caspase-
12/ mice at this time point, suggesting an equivalent level of
caspase-1 activity (Figure 2E). Additionally, we examined cas-
pase-1 activity by detecting caspase-1 processing on western
blot. Caspase-1 was equally processed in both mouse geno-
types into the p10+p20 fragment and fully processed into the
p10 subunit in wild-type but not caspase-12/ mice
(Figure 2F). This result, in combination with the IL-1b ELISA148 Cell Host & Microbe 3, 146–157, March 2008 ª2008 Elsevier Inc.
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prior to phagocyte infiltration in the intestine, caspase-12 was in-
hibiting a pathway essential for C. rodentium killing but distinct
from the caspase-1 inflammasome pathway. We extended our
investigation of the mechanism by monitoring the expression
levels of various genes predicted to play a role in early defenses
to pathogenic bacteria, including cytokines, chemokines, and
antimicrobial peptides. Three genes significantly differed in their
expression levels between the two mouse genotypes. In the
cecum, at 8 hr postinfection, TNFa and MCP-1 were produced
at 6- and 2-fold higher levels, respectively, in caspase-12/
mice compared to wild-type mice (Figure 3D). However, as infec-
tion proceeded, their levels became lower in the ceca of cas-
pase-12/ mice compared to that of wild-type mice, possibly
due to bacteria accumulating at higher levels in ceca of wild-
type mice (Figure 1C, left panel). TNFa and MCP-1 production
is not regulated by the inflammasome, further supporting our
findings that hyperactivation of the caspase-1 pathway is not
at the basis of the differential bacterial growth in this case. In ad-
dition to the early ‘‘burst’’ of TNFa and MCP-1 observed in the
ceca of caspase-12-deficient mice, we found that caspase-12-
deficient enterocytes hyperproduced antimicrobial peptides,
specifically mouse b defensin 1 (mBD1), by more than 10-fold
compared to wild-type cells in both the colon (Figure 2G) and
the cecum (Figure 3E). Previous studies have shown that mBD1
is essential for innate immunity at epithelial surfaces (Morrison
et al., 2002; Moser et al., 2002). Zone-of-inhibition assays were
performed in order to determine whether this increase in mBD1
production accounted for the early C. rodentium killing in cas-
pase-12/ mice. Extracts derived from caspase-12-deficient
colonic or cecal epithelial cells collected 3 days postinfection
exhibited a stronger bactericidal activity against C. rodentium
than did epithelial cell extracts derived from wild-type mice
(Figure 3F). These results suggested that antimicrobial peptide
production may constitute an early defense mechanism against
C. rodentium and that this mucosal response is upregulated in
the absence of caspase-12.
The Bacterial Type III Secretion System of C. rodentium
and the Pathogen Sensors Nod1 and Nod2 Are Essential
for the Antimicrobial Responses
Since TLR signaling appears to contribute to the pathogenesis
rather than the host defense to attaching and effacing patho-
gens, we hypothesized that intracellular PRRs might be in-
volved in innate immunity to these bacteria. For cytosolic
PRRs to be activated, however, bacterial products must reach
the cytosol. As attaching and effacing pathogens are extracel-
lular noninvasive bacteria, we tested whether their type III se-
cretion apparatus was required for the activation of the antimi-
crobial response. In addition, we tested the effect of C.
rodentium DBS100 DcesT, a mutant bacteria deficient in the
CesT chaperone, which is required for the secretion of protein-
aceous bacterial effectors into host cells (Creasey et al., 2003;
Thomas et al., 2005). HT29 colonic cells were infected either
with wild-type C. rodentium, a mutant type III secretion sys-
tem-defective bacteria (C. rodentium DBS100 DescN, hereafter
referred to as DTTSS), or C. rodentium DBS100 DcesT mutant
(Deng et al., 2004). We examined the attachment of all three
bacterial strains on HT29 and whether any invasion occurredCin this cell system. We found no significant invasion in HT29
cells (percent intracellular bacteria for all three strains <
0.008%) and equivalent attachment by all three bacterial strains
(Table S1A). Our results indicated that, while wild-type C. ro-
dentium induced the expression of human b defensins, specif-
ically hBD2 in this system, the DTTSS mutant bacteria induced
a more blunted response (Figure 4A). In contrast, C. rodentium
DBS100 DcesT mutant, in which the chaperone CesT is de-
leted, did not block hBD2 induction (Figure 4A), suggesting
that the TTSS is translocating a nonproteinaceous pathogen-
associated molecular pattern into cells independently of cesT
that is inducing the response. Alternatively, formation of the
type III translocation pore itself might either indirectly or directly
regulate the antimicrobial response. The cytosolic pathogen
sensor proteins Nod1 and Nod2 have been previously shown
to regulate hBD2 expression. We therefore examined their
role in the antimicrobial responses to C. rodentium infection.
We reduced their expression levels by RNA interference
(RNAi) in HT29 cells before infecting the cells with C. rodentium
(Figure 4D). While treatment of HT29 cells with a control siRNA
had no effect on the induction of hBD2, MCP-1, TNFa, and IL-8
in response to C. rodentium infection, knockdown of Nod1
(IL-8) or Nod2 (hBD2, TNFa, and MCP-1) dampened this anti-
microbial response (Figures 4B and 4C). These results sug-
gested that both Nod1 and Nod2 are required in the cell’s
antimicrobial responses to C. rodentium infection.
Caspase-12 Is Associated with the Nod Complex
and Modulates Its Activity
To investigate the effect of caspase-12 on Nod signaling, we ini-
tially examined whether caspase-12 interacted with the Nod
complex. We used HEK293T cells cotransfected with caspase-
12, Rip2, Nod1, or Nod2 and determined the binding of cas-
pase-12 in coimmunoprecipitation experiments. Our results indi-
cated that immunoprecipitation of Rip2 (but not that of Nod1 or
Nod2 when transfected alone) resulted in the coimmunoprecipi-
tation of caspase-12. Cotransfection of either Nod1 or Nod2
along with Rip2 did not alter the interaction between caspase-
12 and Rip2 (Figure 5AI). In a reverse coimmunoprecipitation ex-
periment, pull-down of caspase-12 coprecipitated Rip2
(Figure 5AII). To address whether the CARD domain of cas-
pase-12 was involved in this interaction, caspase-12 deletion
mutants were obtained. A mutant lacking the CARD domain,
Caspase-12 DCARD, but not the CARD-only protein, precipi-
tated Rip2 (Figure 5AIII). These results indicated that caspase-
12 bound to Rip2 independently of its CARD domain, which
was consistent with the observation that, when full-length cas-
pase-12 was overexpressed along with Rip2, both the full-length
form of caspase-12 and the 37 KDa cleavage product lacking the
CARD coprecipitated with Rip2 (Figures 5AI and 5AIV). Trunca-
tion of Rip2 was less informative of the Rip2 domain requirement
necessary for this interaction, as deletion of either the N termi-
nus, in the Rip2 CARD-only protein, or that of the CARD domain,
in Rip2 DCARD, equally abrogated the binding of Rip2 to cas-
pase-12 (Figure 5AIV). In order to examine the downstream ef-
fects of this association in a more physiologic system, we then
tested whether treatment of mouse intestinal epithelial cells
with Nod ligands resulted in the recruitment of caspase-12 to
the Nod complex. To induce the expression of caspase-12 inell Host & Microbe 3, 146–157, March 2008 ª2008 Elsevier Inc. 149
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Caspase-12 Modulates NOD Signal TransductionFigure 2. Caspase-12/ Mice Have a Less Severe Pathology in Response to C. rodentium Infection
(A) Attaching and effacing C. rodentium was detected in colonic sections from wild-type but not caspase-12/ mice on day 7 postinfection. Top panels are
images from H&E-stained colonic sections. Attaching and effacing bacteria stained blue on the surface of epithelial cells (black arrows in insets). Blue arrows
indicate lesions in the colon. Black arrows indicate inflammatory infiltrates. Lower panels are immunofluorescence images with red staining C. rodentium in colon
sections derived on day 14 postinfection.
(B) Histopathology scores evaluating the infectious colitis phenotype induced by C. rodentium on day 14 postinfection. 0 = absent, 1 = modest, 2 = moderate,
3 = severe.
(C) Colonic sections from wild-type and caspase-12/ mice obtained on day 14 postinfection were stained by immunofluorescence with F4/80, Gr-1, and CD4
antibodies to label macrophages, neutrophils, and CD4 T cells, respectively.
(D) RNA extracted from colons of wild-type and caspase-12/ mice on different time points postinfection was analyzed by quantitative real-time PCR. Data
represent average expression ± SEM from five different mice per genotype.150 Cell Host & Microbe 3, 146–157, March 2008 ª2008 Elsevier Inc.
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treated the cells with IFNg, which is known to regulate cas-
pase-12 expression (Kalai et al., 2003) (Figure 5B, left panel).
We followed the ability of caspase-12 to cleave itself in trans
as a ‘‘read-out’’ of its oligomerization in the Nod complex. We
used an in vitro transcribed and translated 35S-methionine la-
beled catalytically inactive caspase-12 (caspase-12 C299A) as
a substrate, which we incubated with lysates derived from
treated cells as a source of the caspase-12 enzyme, and per-
formed an in vitro cleavage assay. Our results indicated that cas-
pase-12 was oligomerized and hence activated in response to
the Nod1 ligand diaminopimelic acid (DAP) or overexpression
of Nod2 or Rip2 (Figure 5B, lower left panel). The Nod2 ligand
muramyl dipeptide (MDP) did not activate caspase-12, possibly
due to lack of expression of Nod2 in these cells at the steady
state (Figure 5B, upper left panel). In conditions in which cas-
pase-12 was activated, the cell death caspases were not, as
determined by lack of cleavage of the fluorogenic tetrapeptide
(E) IL-1b levels were determined by ELISA assays on colonic extracts derived from mice on day 7 postinfection.
(F) Proteins in colonic extracts derived from mice on day 7 postinfection were separated on SDS-PAGE gel, transferred on nitrocellulose membrane, and probed
with an antibody directed against the small (p10) subunit of caspase-1.
(G) RNA extracted from colons of wild type and caspase-12/ mice on different time points postinfection was analyzed by quantitative real-time PCR. Data
represent average expression ± SEM from five different mice per genotype.
Figure 3. Caspase-12/ Epithelial Cells Hyperproduce
Antimicrobial Peptides Early On during C. rodentium Infection
(A) Lack of phagocyte infiltration in the ceca and colons of both wild-type
and caspase-12/ mice on day 3 postinfection withC. rodentium.Cecum
and colon sections were stained by immunofluorescence with F4/80 and
Gr-1 antibodies to label macrophages and neutrophils, respectively.
(B) RNA extracted from colons of wild-type and caspase-12/ mice was
analyzed by quantitative real-time PCR for IL-1b levels at different time
points during infection. IL-1b levels were equivalent in both mouse geno-
types at early time points but became more elevated in wild-type mice at
later time points, as bacterial burden increased more substantially in these
mice compared to caspase-12/ mice.
(C) IL-1b levels were determined by ELISA assays on cecal extracts
derived from mice on day 3 postinfection.
(D) RNA extracted from ceca of wild-type and caspase-12/ mice was
analyzed by quantitative real-time PCR at different time points postinfec-
tion.
(E) RNA extracted from ceca of wild type and caspase-12/ mice was an-
alyzed by quantitative real-time PCR at different time points postinfection.
Data represent average expression ± SEM from five different mice per
genotype.
(F) Colonic and cecal epithelial cell extracts from caspase-12/ mice
have a stronger bactericidal activity against C. rodentium compared to
that from wild-type mice. Epithelial cell extracts were prepared on day 3
postinfection, and bactericidal activity was assessed in zone-of-inhibition
assays as described in the methods. Extraction buffer was added as
a negative control (data not shown). On average the diameter of the
zone of inhibition was 1.4 ± 0.3 cm by Csp-12/ lysates compared to
0.5 ± 0.1 cm by Csp-12+/+lysates. Similar results were obtained when
lysates were prepared from the cecum or the colon.
Data in (B) and (D) represent average expression ± SEM from five different
mice per genotype.
substrate Ac-DEVD-AMC by epithelial cell lysates
(Figure S1). We next examined the effect of caspase-12 re-
cruitment to the Nod complex on Nod signaling by monitor-
ing NF-kB activation. Our results indicated that recruitment
of caspase-12 to the Nod complex correlated with inhibition of
NF-kB signaling downstream of Nod activation (Figure 5B, right
panel). This was also observed in HEK293T cells in which over-
expression of caspase-12 blocked the MDP-induced activation
of NF-kB in Nod2- and Nod2/Rip2-transfected cells (Figure 5C,
left panel). In addition to the NF-kB-luciferase reporter system
we used to assess NF-kB activity, we examined NF-kB signaling
by following the degradation of the inhibitor of NF-kB, IkB, in
peritoneal macrophages derived from caspase-12/ or cas-
pase-12+/+ mice following transfection with MDP. Our results
showed that there were lower levels of IkB in caspase-12/ cells
as compared to wild-type cells and that the rate of degradation
of IkB was faster in caspase-12/ cells compared to wild-type
cells in response to MDP (Figure 5C, middle and right panels).
To address whether processing of caspase-12 substrates might
mediate its effects on Nod signaling, we transfected HEK293T
cells with a vector control, rodent caspase-12, or a catalytically
inactive mutant (caspase-12 C299A) and examined the levels ofCell Host & Microbe 3, 146–157, March 2008 ª2008 Elsevier Inc. 151
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facing bacteria. Our results indicated that both wild-type and
caspase-12 C299A had an equivalent effect on the regulation of
MCP-1 induction in response to infection (Figure S2), suggesting
that the catalytic activity of caspase-12 might not be essential in
this response.
Caspase-12 Displaces Traf6 from the Nod-Rip2
Complex and Inhibits Its Ubiquitin Ligase Activity
Our results indicating that the CARD domain of caspase-12 was
dispensable for its association with Rip2 suggested that the
binding between the two proteins might not involve a CARD-
CARD interaction. Therefore, we examined whether caspase-
12-modulated protein interactions are mediated by the interme-
diate or kinase domains of Rip2. The E3 ubiquitin ligase Traf6 has
been recently shown to bind Rip2 through its kinase domain. The
recruitment of Traf6 to the Nod-Rip2 complex causes its activa-
tion and autoubiquitination as well as the polyubiquitination on
K63 of both Rip2 and IKKg or Nemo (Abbott et al., 2007; Hase-
gawa et al., 2008). These ubiquitination events transmit an acti-
vating signal to the TAB2-TAK1 kinase complex, which in turn
stimulates the IKK complex resulting in the activation of NF-kB
(Abbott et al., 2007; Hasegawa et al., 2008; Figure 7, left panel).
To address if caspase-12 regulated the binding of Traf6 to Rip2,
we performed coimmunoprecipitation experiments. Our results
indicated that the expression of increasing amounts of
caspase-12 led to loss of binding between Rip2 and Traf6
Figure 4. The Type III Secretion System of Attaching and Effac-
ing Bacteria and the Host Pathogen Sensors Nod1 and Nod2
Are Required for the Antimicrobial Responses
(A) HT29 cells were infected with C. rodentium, a type III secretion-defec-
tive mutant C. rodentium DBS100 DescN, or C. rodentium DBS100 DcesT
mutant, which is defective in the chaperone CesT, which is required for the
secretion of proteinaceous bacterial effectors in host cells, and the level of
human b defensin 2 (hBD2) was determined by quantitative real-time PCR.
(B and C) HT29 cells were transfected with a control (GFP), Nod1, or Nod2
siRNA for 48 hr, then infected with wild-type C. rodentium for 6 hr. (B) RNA
was extracted and analyzed by quantitative real-time PCR. (C) Cells were
incubated for an additional 18 hr in fresh media with antibiotics, and the
media were then analyzed by bead-based immunoassays for TNFa.
Data are from triplicate wells per treatment from a representative experi-
ment.
(D) Western blot analysis indicating Nod1 and Nod2 knockdown. Asterisk
represents a nonspecific band that shows equal loading.
(Figure 6AI, lanes 1–3). Interestingly, expression of cas-
pase-12 DCARD at equimolar concentration with Traf6
(Figure 6AIII, lane 4) similarly resulted in the competition of
Traf6’s binding to Rip2, leading to preferential coimmunopre-
cipitation of caspase-12 DCARD with Rip2 (Figure 6AI,
lane 4). These results suggested that the affinity of binding
between caspase-12DCARD and Rip2 is higher than that be-
tween Traf6 and Rip2, and that the expression of caspase-12
displaces Traf6 from the Nod-Rip2 complex. Further support
of these results came from experiments performed to exam-
ine the ubiquitin ligase activity of Traf6 in the absence or pres-
ence of caspase-12. We first examined the autoubiquitina-
tion of Traf6. To do this, we expressed Traf6 along with
Rip2 and HA-ubiquitin and immunoprecipitated Traf6. Our re-
sults showed that, in the absence of caspase-12, immunopre-
cipitated Traf6 was polyubiquitinated (Figure 6AII, lane 5).
Expression of caspase-12, on the other hand, significantly abro-
gated the activity of Traf6 and its autoubiquitination (Figure 6AII,
lane 6). These results were also mirrored when whole-cell
extracts were probed for the expression of Traf6 (Figure 6AIII,
lanes 5 and 6). Similarly, expression of caspase-12 DCARD at
equal or 5-fold lower amounts than that of Traf6 also led to
inhibition of Traf6’s autoubiquitination (Figure 6B, lanes 6 and 7).
Reciprocally, the autoubiquitination of Traf6 was restored when
Traf6 was expressed at 4- or 6-fold higher concentrations than
that of caspase-12 (Figure 6B, lanes 3 and 4). In addition to the
autoubiquitination of Traf6, polyubiquitination of Rip2 was also in-
hibited by caspase-12 (Figure 6AIV, lanes 5 and 6). Altogether, our
results show that, in the absence of caspase-12, Traf6 is activated
in a Rip2-dependent fashion, and that caspase-12 dampens
NF-kB signaling and downstream antimicrobial responses by act-
ing at the level of the displacement of Traf6 from the Nod complex
(Figure 7). We propose a model whereby the Nod signalosome,
which is assembled through a CARD-CARD interaction between
Nod and Rip2, and through the binding of Traf6 to the kinase
domain of Rip2, is disrupted by caspase-12.
DISCUSSION
Phylogenetically, caspase-12 belongs to the caspase-1 inflam-
matory caspase subfamily. While caspase-1 is activated within152 Cell Host & Microbe 3, 146–157, March 2008 ª2008 Elsevier Inc.
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some, the molecular mechanisms resulting in caspase-12 acti-
vation are less well known. We have previously shown that
rodent caspase-12 inhibited caspase-1 independently of its
catalytic activity, suggesting that it acted as a dominant-nega-
tive regulator of the inflammasome. Here we show that, in the
enterocyte, caspase-12 modulated the Nod signalosome. Cas-
pase-12-deficient mice hyperproduced b defensins and a sub-
set of cytokines and chemokines, independently of caspase-1,
but in a Nod-dependent manner. Importantly, we present
results indicating that stimulation of Nod proteins resulted in
the recruitment of caspase-12 to the Nod complex. Caspase-
12 bound to Rip2 and displaced Traf6 from the complex, which
led to inhibition of Nod signaling and blunting of the antimicro-
bial responses (Figure 7). Concomitantly, recruitment of cas-
pase-12 to the Nod complex led to its oligomerization and ac-
tivation by proximity (Figure 7). Interestingly, the activation of
caspase-12 by Nod stimuli occurred only when cells were
treated with IFNg, but not when caspase-12 was overex-
pressed by transfection, suggesting that IFNg induced the ex-
pression of a factor required for caspase-12 activation in the Nod
complex. We still do not know whether caspase-12 substrates
other than caspase-12 itself are targeted downstream of the Nod
complex. However, our results showing that the catalytically inac-
tive caspase-12 mutant had an inhibitory activity on MCP-1
production in response to infection with attaching and effacing bac-
teria equivalent to that of wild-type caspase-12 suggested that the
enzymatic function of caspase-12 might not be crucial for the
observed antimicrobial responses.
Nod activation is an important innate immune defense mech-
anism in the gut. We show that the pathogenic attaching and ef-
facing bacteria C. rodentium activates the Nod pathway in a type
III secretion system-dependent manner. The host responds to
these pathogens by stimulating the production of ‘‘alarmins’’ in-
cluding cytokines, chemokines, and b defensins. We show that
these antimicrobial responses were enhanced in the absence
of caspase-12, resulting in a more efficient eradication of the
bacteria very early during infection. Attaching and effacing path-
ogens could evade phagocytosis (Celli and Finlay, 2002), and
TLRs, which are highly expressed on the surface of phagocytes
but less so on that of enterocytes, do not seem to be essential for
the host resistance to these microbes. The host appears to utilize
antimicrobial peptides derived from epithelial cells as an innate
defense strategy against these pathogens. The colitis phenotype
induced by the persistent presence of the bacteria at the peak of
infection is, on the other hand, TLR4 dependent and is mediated
predominantly by macrophages, neutrophils, and Th1 lympho-
cytes.
Caspase-12 is truncated in the majority of the human popula-
tion due to a single-nucleotide polymorphism (SNP) that intro-
duces a stop codon in exon 4 of its gene (Fischer et al., 2002;
Saleh et al., 2004). However, in 20% of African descendents an
arginine replaces the stop codon and results in the synthesis of
a full-length protein (Saleh et al., 2004). We have previously
shown that the full-length caspase-12 variant is more deleterious
than the truncated CARD-only variant through its ability to act as
a dominant-negative suppressor of inflammation. Our results
showing that caspase-12 blocked Nod signaling independently
of its CARD domain instructs us on the mechanism by whichCthe full-length variant might exerts its differential negative effects
on inflammation and innate immunity. In addition, as Nod2 is
mutated in the inflammatory bowel disorder Crohn’s disease, it
is tempting to speculate that, by modulating its signaling, cas-
pase-12 might have a modifier effect in CD. It would be therefore
interesting to examine whether homozygote carriers of the full-
length caspase-12 variant suffer from a more severe pathology.
We have previously shown that caspase-12 predisposed the
organism to polymicrobial sepsis (Saleh et al., 2004; Saleh
et al., 2006). We propose that, in addition to its role in inhibiting
the inflammatory caspase-1 pathway in macrophages, its func-
tion in the epithelium in dampening the production of ‘‘alarmins,’’
including antimicrobial peptides and chemokines, may contrib-
ute to its negative effects during sepsis.
EXPERIMENTAL PROCEDURES
Infection of Mice
Four-week-old female C57BL/6 mice were from Jackson Laboratories. Cas-
pase-12-deficient mice (Csp12/), previously described by Saleh and col-
leagues (Saleh et al., 2006) were bred and maintained at the McGill Univer-
sity Health Centre Animal Facility. Mice were orally inoculated with wild-type
C. rodentium strain DBS100 rendered resistant to chloramphenicol (CM) by
the insertion of a mini-Tn7 transposon encoding chloramphenicol resistance
into the glmS gene. The resulting strain was shown to be indistinguishable
from the parental strain in terms of infectivity and kinetics during mouse in-
fection (Wickham et al., 2007). For inoculations, bacteria were grown over-
night in 3 ml Luria-Bertani (LB) broth supplemented with CM (20 mg/ml)
with shaking at 37C. Mice were infected by oral gavage with 0.1 ml of
LB containing approximately 2.5 3 108 CFU of C. rodentium. Four hours
prior to infection, food and water were removed from the cages and
returned 2 hr postinfection (p.i.). Mice were sacrificed at various time points
p.i., and tissues were prepared for histological analysis, viable bacterial
counts, RNA isolation, ELISA assays, and zone-of-inhibition assays, as
described below.
Zone-of-Inhibition Assays
Cecum and colon epithelial cells were isolated from infected wild-type and
caspase-12-deficient mice. For protein lysates, epithelial cells were homoge-
nized in 10 mM phosphate buffer (pH 7.0), containing 0.1% Triton X-100 and
centrifuged at 14,000 3 g for 20 min. C. rodentium (107 CFU/ml) were added
to 1.5% agarose in 10 mM phosphate buffer (pH 7.0) containing tryptone
(5 mg/ml) and plated in a 3 mm layer in 10 cm plastic dishes. Cecal and colonic
epithelial cell lysates were added to small wells punched in the assay plates.
Histopathological Analysis and Immunohistochemistry
Ceca and colons were fixed in 10% formalin and embedded in paraffin. Serial
5 mm thick sections were cut onto glass slides and stained with hematoxylin
and eosin. Sections were blindly assessed for signs of infectious colitis. For im-
munohistochemistry, slides were dewaxed at room temperature in xylene for
two changes, 5 min each, and rehydrated in two changes of ethanol (100%,
95%, 70%), 5 min each, followed by water. Antigen retrieval was performed
by incubation in 0.1 M citrate buffer (pH 6.0) at 95C for 10 min. After several
washes in PBS 0.2% Tween 20, the slides were blocked with fetal bovine
serum (FBS) for 30 min at 37C. Samples were then incubated with rat mono-
clonal primary antibodies against mouse macrophages, neutrophils, or CD4
T cells at a 1:200 dilution. Antibodies were from Serotech. Slides were then
washed with PBS-Tween and incubated with Alexa 594-conjugated anti-rat
IgG secondary antibodies (Molecular Probes) for 1 hr at 37C. The slides
were finally rinsed and mounted with permafluor mounting media.
RNA Extraction and SYBR Green Quantitative RT-PCR Analysis
Total RNA was extracted from cecum, colon, HT29, or HEK293T cells using
Trizol reagent (Invitrogen) followed by chloroform extraction and isopropanol
precipitation. Two micrograms total RNA was reverse transcribed to cDNA
using M-MLV reverse transcriptase (Invitrogen) using random hexamers inell Host & Microbe 3, 146–157, March 2008 ª2008 Elsevier Inc. 153
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Caspase-12 Modulates NOD Signal TransductionFigure 5. Caspase-12 Is Recruited to the Nod/Rip2 Complex, Is Activated by Nod Triggers, and Inhibits Nod Signaling
(A) (AI) Extracts from HEK293T cells transfected with rodent caspase-12, Flag-Nod1, Nod2, Flag-Rip2, or a vector control were immunoprecipitated with anti-Flag
(M2 beads) or anti-Nod2 antibodies, and the coimmunoprecipitation of caspase-12 was determined by western analysis. (AII) Extracts from HEK293T cells trans-
fected with rodent caspase-12, Flag-Rip2, or a vector control were immunoprecipitated with anti-caspase-12 antibodies, and the coimmunoprecipitation of Flag-
Rip2 was determined by western analysis. C, control vector; IP, immunoprecipitated complex; *IgG heavy and light chains. (AIII) Extracts from HEK293T cells
transfected with Flag-RIP2, Myc-caspase-12 CARD, Myc-caspase-12 DCARD, or a vector control were immunoprecipitated with anti-Myc antibodies, and
the coimmunoprecipitation of Flag-Rip2 was determined by western analysis. (AIV) Extracts from HEK293T cells transfected with rodent caspase-12, Flag-
Rip2, Flag-RIP2 CARD, Flag-RIP2 DCARD, or a vector control were immunoprecipitated with anti-Flag antibodies, and the coimmunoprecipitation of cas-
pase-12 was determined by western analysis. For I, II, III, and IV, top panels represent the IP result, while the lower panels represent expression control western
blots.
(B) (Left panel) The murine intestinal epithelial cells, MODE-K cells, were left untreated, treated with IFNg, or transfected with rodent caspase-12. In addition, cells
were either treated with the Nod2 ligand muramyl dipeptide (MDP) or the Nod1 ligand diaminopimelic acid (DAP) or transfected with a vector control, Nod2 or
Rip2. Lysates from untreated or treated cells were examined for caspase-12 cleaving activity, which is indicative of endogenous caspase-12 enzyme activation,
by incubating the lysates with an 35S-labeled catalytically inactive caspase-12 C299A substrate, and an in vitro caspase cleavage assay was performed (bottom
panel). The expression levels of Nod2 and caspase-12 were determined by western analysis (top panels). (Right panel) Cells described above were additionally
transfected with kB-luciferase and b-galactosidase reporters. NF-kB activity was determined using luciferase assays.154 Cell Host & Microbe 3, 146–157, March 2008 ª2008 Elsevier Inc.
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Caspase-12 Modulates NOD Signal Transductiona volume of 20 ml according to the manufacturer’s protocol. Quantitative
RT-PCR primers for different antimicrobial peptides, cytokines, and chemo-
kines are described in Tables A and B of the Supplemental Experimental
Procedures.
Cell Culture and Infection
The following bacterial strains were used for cell infection: wild-type C.
rodentium DBS100, C. rodentium DBS100 DescN, C. rodentium DBS100
(C) (Left panel) HEK293T cells transfected with kB-luciferase and b-galactosidase reporters and with rodent caspase-12, Nod2, Flag-Rip2, or a vector control
were treated 24 hr following the transfection with 10 mg/ml MDP for one overnight. NF-kB activity was determined using luciferase assays. (Middle panel) Peri-
toneal macrophages derived from caspase-12/ or wild-type mice were transfected with MDP using DOTAP. Cells were lysed at different time points following
transfection, and IkB degradation was assessed by western analysis. Blots were reprobed with anti-actin antibodies to control for loading. (Right panel) The
relative intensity of the bands on the IkB and actin blots were determined, the intensity of the IkB bands was normalized to that of the actin bands, and the
corrected values plotted.
Figure 6. Caspase-12 Displaces Traf6 from the Nod-Rip2
Signaling Complex and Inhibits Its Activation
(A) (AI) Extracts from HEK293T cells transfected with caspase-12 (1, 2, or
3 mg in 10 cm plates), Myc-Traf6, Myc-caspase-12 DCARD, Flag-Rip2, or
a vector control were immunoprecipitated with anti-Flag antibodies (M2
beads), and the coimmunoprecipitation of Myc-tagged proteins (Traf6 or
caspase-12 DCARD) was determined by western analysis. (AII) Extracts
from HEK293T cells transfected with Myc-Traf6, HA-ubiquitin, caspase-
12, or a vector control were immunoprecipitated with anti-Myc antibodies,
and the coimmunoprecipitation of HA-tagged ubiquitinated proteins was
determined by western analysis. *IgG light chains. (AIII) Expression control
western blot on whole-cell extracts (WCE) with anti-Myc antibodies. (AIV)
Expression control western blot on whole-cell extracts (WCE) with anti-
Flag antibodies. (AV) Expression control western blot on whole-cell
extracts (WCE) with anti-caspase-12 antibodies. Arrow designates full-
length caspase-12, and white arrowhead represents caspase-12 cleav-
age products. (AVI) Expression control western blot on whole-cell extracts
(WCE) with anti-HA antibodies to reveal total cellular ubiquitinated
proteins.
(B) Both caspase-12 and Caspase-12 DCARD inhibited the autoubiqui-
tination of Traf6. Extracts from HEK293T cells transfected with
caspase-12, Myc-Traf6, Myc-caspase-12 DCARD, HA-ubiquitin, and
a vector control were probed for the expression of Myc-tagged
proteins.
DcesT, and wild-type enteropathogenic EPEC strain E2348/69. All
strains were grown from single colonies on LB plates in LB broth at
37C standing overnight culture. Human colon epithelial cells HT29
and HEK293T cells were grown in McCoy’s 5A modified medium (Sigma)
and DMEM (GIBCO), respectively, supplemented with 10% heat-inacti-
vated FBS (Hyclone Laboratories) and 2 mM glutamine. Subconfluent
monolayers of cells were kept in a humidified incubator at 37C with
5% CO2. HT29 and HEK293T cells were infected for 6 hr at a multiplicity
of infection (moi) of 1:1.
Transient Transfections
Human embryonic kidney 293T (HEK293T) cells were seeded in 6-well
plates and used for transfection at 50%–70% confluence. Cells were trans-
fected with an empty GFP vector or the indicated plasmids (Csp12, Csp12
C299A) using lipofectamine plus reagent (Invitrogen) according to the manu-
facturer’s instructions. Twenty-four hours after transfection, cells were
infected with EPEC for 6 hr. After infection, total RNA was extracted using
Trizol reagent (Invitrogen).
Plasmids
To clone caspase-12 CARD, caspase-12DCARD, RIP2-CARD, and RIP2-
DCARD, PCR was performed on full-length caspase-12 or Rip2 cDNA,
respectively, using primers that introduce a Flag tag in the Rip2 deletion
mutants and a Myc tag in the caspase-12 deletion mutants. PCR products
were digested with HindIII and XhoI and cloned in pcDNA3.1+. Plasmids were
verified by sequencing. For the sequence of primers, please refer to the
Supplemental Experimental Procedures.
Coimmunoprecipitation
Human embryonic kidney 293T (HEK293T) cells were cultured in DMEM sup-
plemented with 10% FBS. Transient transfections were performed using Lip-
ofectamine Plus reagent (Invitrogen). HEK293T cells were transfected with ratCell Host & Microbe 3, 146–157, March 2008 ª2008 Elsevier Inc. 155
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Caspase-12 Modulates NOD Signal Transductioncaspase-12 along with pcDNA3.1, Flag-Nod1, Nod2, or Flag-Rip2. In other
experiments cells were transfected with Myc-tagged caspase-12 CARD,
Myc-tagged caspase-12 DCARD, Flag-tagged Rip2 CARD, or Flag-tagged
Rip2 DCARD, Myc-tagged Traf6, and HA-tagged ubiquitin. At 24 hr after trans-
fection, HEK293T cells were washed in PBS, harvested, and lysed on ice for
30 min in buffer B150 (20 mM Tris-HCl [pH 8.0], 150 mM KCl, 10% glycerol,
5 mM MgCl2, 0.1% NP-40, and protease inhibitors). Supernatants were incu-
bated for 2 hr with either M2 agarose beads (Sigma) or the immunoprecipitat-
ing antibody along with protein A or protein G agarose beads at 4C followed
by three washes of the beads with lysis buffer. Immunoprecipitates on protein
A or G beads were eluted by boiling in Laemmli buffer. Immunoprecipitates on
M2 beads were eluted from the beads using Flag peptides (Sigma). IP eluates
were processed for western blot analysis using anti-caspase-12, anti-Flag,
anti-Nod2, or anti-Myc antibodies.
Figure 7. Schematic Depiction of the Mechanism by Which
Caspase-12 Dampens Mucosal Immunity to Attaching and Effacing
Bacteria through Modulation of the Nod-Rip2 Signalosome
Through their type III secretion system, AAE bacteria are sensed by the path-
ogen recognition receptors Nod1 and Nod2 (here Nod2 is depicted). In the
absence of caspase-12 (left panel), Rip2 associates with Nod2 through
a CARD-CARD homotypic interaction and signals to NF-kB activation. This
is mediated via the binding and activation of the E3 ubiquitin ligase Traf6.
Traf6 binds to the kinase domain of Rip2 and upon activation is autoubiqui-
tinated and polyubiquitinates Rip2 (yellow circles). These ubiquitination
events are required for the engagement of the TAB2-TAK1 kinase complex
and the stimulation of the IKK complex (Abbott et al., 2007; Hasegawa
et al., 2008), resulting in NF-kB activation and induction of antimicrobial
responses. In the presence of caspase-12 (right panel), caspase-12 binds
to Rip2 and displaces Traf6 from the Nod signalosome, hence suppressing
its ubiquitin ligase activity and its ability to transduce activating signals to
NF-kB. The expression of caspase-12 therefore results in a blunted signaling
to NF-kB and dampened antimicrobial responses. The recruitment of cas-
pase-12 to the Nod complex stimulates its activation by proximity. However,
caspase-12 catalysis does not seem to be required for its inhibitory effects
on Nod signaling.156 Cell Host & Microbe 3, 146–157, March 2008 ª2008 Elsevier IncMDP Transfection and IkB Degradation Assay
DOTAP cationic lipid (Roche) was used according to the manufacturer’s
instructions. Briefly, 50 ml of DOTAP was incubated for 30 min in OPTI-MEM
I media with 10 mg/ml of purified MDP in a final volume of 0.5 ml. After incuba-
tion, 1.5 ml of OPTI-MEM I media was added, and 0.5 ml was used to stimulate
106 macrophages seeded in 12-well plates for different time points (0, 15, 30,
60 min). At each time point, cells were lysed in 125 ml of B150 buffer. Lysates
were sonicated for 15 s and then spun down at 13,000 rpm for 15 min. For
western blot, 25 mg of total protein lysates were used. The primary antibodies,
anti-IkB-a (Cell Signaling) and anti-actin (Santa Cruz), were diluted 1000 times
in 5% milk in TBS-0.1% Tween. Western blots were quantified using the
ImageJ 1.38X software (National Institutes of Health, Bethesda, MD) after
densitometric scanning of the films.
siRNA Experiments
Gene knockdown was performed using one or two duplexes per
gene: Hs_CARD4_1_HP and Hs_CARD4_4HP siRNAs targeting NOD1,
Hs_CARD15_3_HP and Hs_CARD15_5_HP siRNAs targeting NOD2, and
GFP-22 siRNA as a control were supplied by QIAGEN. HT29 cells were seeded
in 24-well plates 1 day before the transfection at 5 3v104 cells/well in Mac-
Coy’s-5A media (Wisent) supplemented with 10% FBS (Hyclone) and incu-
bated overnight at 37C with 5% CO2 in a humidified incubator. The following
day, cells were washed once prior to transfection with nonsupplemented Mac-
Coy’s-5A media to remove serum and reoverlaid with 160 ml of the same me-
dia. Transfection was carried out with Oligofectamine (Invitrogen): For each
well, 0.8 ml of Oligofectamine was mixed with 2.2 ml of prewarmed Opti-
MEM media (GIBCO) and incubated for 10 min at room temperature. During
this time, 0.187 ml of both 20 mM siRNA duplexes (0.375 ml total) was mixed
with prewarmed Opti-MEM media in a separate tube to 187 ml final volume.
Both mixtures were then mixed together and left to incubate for a further
20 min at room temperature. Forty microliters of the complexed reaction
mixture was subsequently overlaid in each well of the cell culture and left to
incubate for 3 hr, after which 100 ml of MacCoy’s-5A supplemented with
30% FBS was then added to each well. Incubation continued for an additional
42 hr prior to the 6 hr bacterial infection.
Statistical Analysis
Student’s t test was used for statistical analysis of bacterial counts as well as
for cytokine/chemokine and antimicrobial peptide production assays.
SUPPLEMENTAL DATA
The Supplemental Data include Supplemental Experimental Procedures, three
supplemental tables, and two supplemental figures and can be found with this
article online at http://www.cellhostandmicrobe.com/cgi/content/full/3/3/146/
DC1/.
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